An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread

Local Institution - 0055, Clayton

Local Institution - 0123, Buenos Aires

Local Institution, Woluwe-Saint-Lambert

Local Institution - 0119, Buenos Aires

Local Institution - 0044, Blacktown

Local Institution - 0069, Heidelberg

Local Institution - 0043, Southport

Local Institution - 0104, New York

Local Institution - 0100, Lancaster

Local Institution - 0003, Philadelphia

Thomas Jefferson University - Clinical Research Institute, Philadelphia

Local Institution - 0094, Rozzano

Local Institution - 0093, Milan

Local Institution - 0028, Baltimore

Local Institution - 0114, Madrid

Local Institution - 0051, Madrid

Local Institution - 0115, Madrid

Local Institution - 0029, Charlotte

Local Institution - 0004, Hanover

Local Institution - 0080, Pamplona

Local Institution - 0107, Gainesville

Local Institution - 0111, Miami

Local Institution - 0092, Padua

Local Institution - 0022, Birmingham

Local Institution - 0096, Seville

Local Institution - 0103, St Louis

Local Institution - 0071, Brno

Local Institution - 0101, Temple

Local Institution - 0027, Los Angeles

Local Institution - 0067, Los Angeles

Local Institution - 0001, San Francisco

Local Institution - 0095, Catania

Local Institution - 0118, Santiago

Local Institution - 0116, Hattiesburg

Local Institution - 0002, Madison

Local Institution - 0120, Ciudad Autónoma de Buenos Aires

Local Institution - 0122, Buenos Aires

Local Institution - 0068, Elizabeth Vale

Local Institution - 0113, Edmonton

Local Institution - 0070, Toronto

Local Institution - 0077, Montreal

Local Institution - 0076, Ottawa

Local Institution - 0117, Santiago

Local Institution - 0072, Olomouc

Local Institution - 0073, Hradec Králové

Local Institution - 0079, Badalona

Local Institution - 0052, Barcelona